• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Apple adds hypertension notifications to its heart health tools

Apple adds hypertension notifications to its heart health tools

September 10, 2025 By Danielle Kirsh

iPhone and Apple Watch displaying a "Possible Hypertension" alert. The iPhone screen shows a summary of heart data from March 1–31, 2025, indicating patterns related to hypertension and suggesting next steps, including logging blood pressure with a cuff. The Apple Watch screen shows the same alert with a heart icon.
[Image courtesy of Apple]

Apple introduced a new feature that alerts users to signs of chronic high blood pressure, expanding the Apple Watch’s role in heart health monitoring.

The notifications use the optical heart sensor to analyze how blood vessels respond to each heartbeat. An algorithm reviews data over 30-day periods and alerts the user if it detects consistent signs of hypertension.

Apple said the feature was trained on data from more than 100,000 participants and validated in a clinical study of over 2,000 people. The company expects regulatory clearance soon, with rollout in more than 150 countries this month.

“Hypertension is the leading preventable cause of heart attack and stroke, yet millions remain undiagnosed,” said Dr. Harlan Krumholz, cardiologist and scientist at Yale University and Yale New Haven Hospital. “Making accurate detection easy and part of daily life can help people get care earlier and prevent avoidable harm.”

Apple Watch already includes the ECG app, which generates an electrocardiogram to check for atrial fibrillation, and the Heart Rate app, which provides continuous monitoring along with high and low heart rate notifications. Irregular rhythm alerts are also available.

Hypertension notifications will be supported on Apple Watch Series 9 and later, including Series 11 and Apple Watch Ultra 2, with watchOS 26.

Easy-to-use and reliable blood pressure monitoring has been a holy grail for digital health wearables. Over the summer, Aktiia won the first FDA 510(k) clearance for over-the-counter use of a cuffless blood pressure monitor, the G0 Blood Pressure Monitoring System (branded as the Hilo Band). (Wondering if your blood pressure monitor is reliable enough? The American Medical Association supports a validated blood pressure device database that is available online.)

More on Medical Design & Outsourcing: How Aktiia developed the Hilo Band, the first FDA-cleared OTC cuffless blood pressure monitor

Filed Under: Artificial Intelligence (AI), Business/Financial News, Cardiovascular, Digital Health, Featured Tagged With: Apple

More recent news

  • Zenflow nets $52M, Cook Medical deal for in-office enlarged prostate implant
  • Abbott to update CardioMEMS to allow patients to track pulmonary artery pressure
  • Wandercraft acquires exoskeleton rival Ekso Bionics
  • GE HealthCare to buy Sofie Biosciences in $945M radiopharmaceutical play
  • Carlsmed names chief product and AI officer as it claims CMS reimbursements

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy